Official Title
Enhanced Valves Interventions and Safe AI Generated End Results
Brief Summary

This non-interventional study aims to use artificial intelligence to improve theprediction of transcatheter heart valve interventions and optimize patient outcomes. Itis based on the analysis of retrospective data from various specialized centersworldwide.

Detailed Description

The ENVISAGE study is a non-interventional, retrospective research study designed to
validate an artificial intelligence (AI)-based framework for the automated analysis of
cardiac imaging data, including multi-slice cardiac computed tomography (CT) and
transesophageal echocardiography (TEE). The primary objective is to predict the success
of transcatheter heart valve interventions, including aortic, mitral, and tricuspid valve
interventions (TAVI, TMVI, M-TEER, T-TEER). The AI framework developed in this study will
rely on deep learning algorithms, particularly convolutional neural networks (CNNs) and
other advanced models, to automatically segment critical anatomical structures and
perform accurate measurements of these structures from CT and TEE images. These
measurements will then be combined with pre-interventional clinical data to optimize
patient selection and intervention planning, as well as to predict surgical outcomes with
high accuracy. AI will also aim to reduce human error and inter-observer variability in
the interpretation of cardiac images, which could significantly improve clinical
outcomes.

Recruiting
Heart Valve Disease
TAVI
M-TEER
TTVI
TMVI
T-TEER
Mitraclip
TriClip

Diagnostic Test: Medical imaging analysis via artificial intelligence algorithms

Development of AI algorithms based on pre-procedural imaging annotations and clinical
informations to predict the transcatheter procedural outcomes

Eligibility Criteria

Inclusion Criteria:

Patients who have reached the age of legal majority under local laws.

- For TAVI group: All patients who have had TAVI with a third generation transcatheter
heart valve (THV), with an available pre-procedural optimal quality CT scan as
defined by an ECG- gating CT with:

1. five to ten image volumes at cardiac phases from 5% to 95% R-R

2. 0.625 mm slice thickness

3. 0.625 mm spacing between slices

4. 0.88 mm in-plane pixel spacing

- For TMVI group: Patients who have had a TMVI with a dedicated device and screen
failures, with an available optimal quality CT scan.

- For TTVI group: Patients who have had a TTVI with a dedicated device and screen
failures, with an available optimal quality CT scan.

- For M-TEER: All patient who have had a M-TEER with 1) G4 or newer iteration of
MitraClip or 2) G2 or newer iteration of Pascal, with available pre-procedural TEE
videos images from one of two vendors: Phillips or GE, with clear identifiable views
of the Mitral valve, frame per second equal or higher than 40 frames per second,
acceptable 3D reconstructions.

- For T-TEER: All patient who have had a T-TEER with G4 or newer iteration of TriClip
or 2) G2 or newer iteration of Pascal, with available pre-procedural TEE videos
images from one of two vendors: Phillips or GE, with clear identifiable views of the
Tricuspid valve, frame per second equal or higher than 40 frames per second,
acceptable transgastric image with acceptable 3D reconstructions.

Exclusion Criteria:

- For TAVI group: Valve-in-valve procedures

- For TMVI group: Valve-in-valve and valve-in-ring procedures

- For TTVI: Valve-in-valve and valve-in-ring procedures

- For M-TEER: G3 or older MitraClip, G1 Pascal

- For T-TEER: G3 Triclip, G1 Pascal

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Canada
France
Germany
Italy
United States
Locations

Montefiore Medical Center New York
New York 5128581, New York 5128638, United States

Montreal Heart Institute, 5000 Rue Bélanger, Montréal
Montreal 6077243, Quebec 6115047, Canada

St Michael's Hospital Toronto
Toronto 6167865, Canada

St Paul's Hospital Vancouver
Vancouver 6173331, Canada

Centre Hospitalier Universitaire (CHU) de Bordeaux, 12 rue Dubernat 33404 Talence cedex
Bourdeaux 3031069, France

CHU Lille
Lille 2998324, France

CHU Marseille
Marseille 2995469, France

Centre Cardiologique du Nord Paris
Paris 2988507, France

Institut Cardiovasculaire Paris-Sud Paris
Paris 2988507, France

Centre Hospitalier Universitaire Rennes
Rennes 2983990, France

Clinque Pasteur Toulouse - France
Toulouse 2972315, France

University Medical Center Hamburg-Eppendorf
Hamburg 2911298, Germany

Heart Valve Center Mainz
Mainz 2874225, Germany

Istituto Clinico Città di Brescia
Brescia 3181554, Italy

San Raffaele Heart Valve Center Milan
Milan 3173435, Italy

Contacts

Thomas Modine, MD, PhD
+33(0)5 25 377541
thomasmodine@gmail.com

Walid Ben Ali, MD, PhD
+1 5145611037
dr.walidbenali@gmail.com

Montreal Heart Institute
NCT Number
Keywords
Medical Imaging
CT
Artificial Intelligence
M-TEER
T-TEER
TAVI
TMVI
valvulopathy
predictive algorithms
MeSH Terms
Heart Valve Diseases